Design, validation, and functional impact of oligonucleotides for multigene silencing in Alzheimer’s disease

Key Points

• Multigene silencing shows potential in mitigating Alzheimer's disease symptoms.
• The study validates oligonucleotides, achieving a significant reduction in amyloid-beta levels.
• Design and functional testing involved a novel approach to oligonucleotide composition and delivery.
• Further research is needed to explore long-term effects and safety in human trials.